Catalyst Wire Dossier Catalyst Wire Dossier

Equfina

· Eisai Korea Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Equfina, covering 2025-06-22 to 2025-06-22. Get the full timeline:

Most recent: Clinical Trial Update: A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)

See pricing